van der Baan Bastiaan Jeroen 4/A
4/A · LIXTE BIOTECHNOLOGY HOLDINGS, INC. · Filed Jan 5, 2023
Insider Transaction Report
Form 4/AAmended
van der Baan Bastiaan Jeroen
Director
Transactions
- Purchase
Common Stock
2022-12-30$0.49/sh+10,000$4,900→ 10,000 total